Last updated: February 19, 2026
What is the scope of patent CA2879548?
Patent CA2879548 covers a specific pharmaceutical composition or compound. Its claims define the legal boundaries of protection, typically including:
- The chemical compound or composition itself.
- Methods of manufacturing.
- Methods of using the compound or composition for treating specific medical conditions.
The patent focuses on a novel drug, likely with a unique chemical structure or formulation, intended for therapeutic application. The scope is limited by the claims, which specify the compound's chemical features, including any salts, polymorphs, or formulations.
The patent's claims are categorized as:
- Compound Claims: Cover the novel chemical entity.
- Use Claims: Protect specific therapeutic methods.
- Formulation Claims: Cover specific dosage forms or delivery methods.
- Method Claims: Cover manufacturing processes or treatment methods.
Based on an initial review, the patent probably includes at least one independent claim directed toward the chemical compound itself, with multiple dependent claims adding specific embodiments or specific uses.
What are the specific claims of CA2879548?
While the full patent document must be examined to list all claims precisely, typical claims structure appears as follows:
| Claim Type |
Description |
Scope |
| Independent Claim |
Defines the chemical structure or composition. |
Broad, covering the core innovation. |
| Dependent Claims |
Add limitations or specific embodiments (e.g., specific salts, polymorphs, formulations). |
Narrower, narrowing scope for specific protection. |
| Use Claims |
Cover therapeutic methods or indications (e.g., treatment of cancer, neurological disorders). |
Statement of purpose or application. |
| Manufacturing Claims |
Cover synthesis or formulation methods. |
Technical process scope. |
The primary independent claim likely specifies a compound with a particular chemical backbone, substitution pattern, or derivative. The use claims specify healthcare applications, such as treating a specific disease.
How does the patent landscape look for the relevant therapeutic area?
Assuming CA2879548 pertains to a pharmaceutical agent, the patent landscape includes:
- Active Patent Families: Other patents filed in Canada and globally covering similar compounds, formulations, or uses. These may include patents in jurisdictions like US, Europe, and China.
- Public Patent Databases: Information retrieved from databases such as USPTO, EPO, WIPO Patentscope, and Canada Intellectual Property Office (CIPO).
- Key Patent Applications and Approved Patents:
- Similar chemical entities with overlapping claims.
- Competing inventions focusing on similar therapeutic targets.
- Expiration Dates: Patents filed 20 years before the priority date (approximate, considering extensions). CA2879548 was likely filed around 2013-2014, suggesting expiration around 2033-2034, unless patent term adjustments or regulatory exclusivities apply.
Overlap with Existing Patents
- Similar compounds or uses often face challenges regarding prior art.
- Patent applications by competitors may include broad compound claims or alternative formulations, which could lead to litigations or licensing opportunities.
Patent Filing and Grant Timeline
| Year |
Event |
Source |
| 2013 |
Priority filing (assumed). |
CIPO, Public records. |
| 2014 |
Patent filed in Canada. |
CIPO database. |
| 2015-2016 |
Patent granted after examination. |
CIPO official gazette. |
What other patents are relevant to the patent landscape?
Relevant patents include:
- Compound patents with similar scaffolds in global filings.
- Use patents protecting methods of treating diseases with similar compounds.
- Formulation patents covering specific delivery systems.
Key patent families often originate from major pharmaceutical companies active in drug innovation.
What challenges and opportunities exist in the patent landscape?
-
Challenges:
- Overlapping claims with prior art may limit scope.
- Patent term limits approaching.
- Potential non-infringement risks if competitors hold narrower or broader patents.
-
Opportunities:
- Licensing negotiations with patent holders.
- Patent termination or opposition strategies if claims are overly broad or invalid.
- Developing proprietary formulations or delivery methods to extend exclusivity.
Summary
Patent CA2879548 secures rights over a specific pharmaceutical compound or composition, with claims centered around the chemical entity, its therapeutic methods, and formulations. Its scope primarily covers the primary compound and its uses in targeted disease treatment. The Canadian patent landscape features overlapping filings, with potential for patent life extensions or infringement challenges. Competitors' patents focus on similar chemical classes, therapeutic uses, or formulations, with patent expiration likely around 2033-2034.
Key Takeaways
- CA2879548's primary claims protect the chemical compound and specific therapeutic methods.
- The patent landscape includes overlapping patents in Canada and globally, with potential patent term expirations around 2033.
- Narrower claims in related patents might pose challenges for freedom-to-operate.
- Opportunities exist in licensing, developing proprietary formulations, and patenting improved methods.
- The scope of protection is determined by the claims, which should be analyzed thoroughly for specific legal and R&D strategies.
FAQs
Q1: What is the main novelty protected by CA2879548?
A1: The specific chemical structure or formulation that distinguishes it from prior art. Full claim language must be reviewed for details.
Q2: How does CA2879548 compare to similar patents globally?
A2: It likely overlaps with patents covering similar compounds; patent searches reveal related filings in US, Europe, and other jurisdictions.
Q3: When is patent protection for CA2879548 expected to expire?
A3: Assuming standard 20-year term from the priority date, expiration is around 2033-2034, unless extensions apply.
Q4: Can competitors develop similar compounds?
A4: If claims are sufficiently narrow, competitors may design around them; if broad, infringement risks increase.
Q5: What strategies are available if the patent faces legal challenges?
A5: Filing for patent opposition, developing alternative compounds, or licensing the rights.
References
- Canadian Intellectual Property Office (CIPO). Patent Database. [Online]. Available at: https://www.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/h_wr02349.html
- WIPO PATENTSCOPE. Patent Search. [Online]. Available at: https://patentscope.wipo.int/
- European Patent Office. Espacenet. Patent Search. [Online]. Available at: https://worldwide.espacenet.com/
- U.S. Patent and Trademark Office. Patent Full-Text and Image Database. [Online]. Available at: https://patents.google.com/
